Reese, S. E.

About

Publications While At HealthPartners

selected publications

Journal Article

18 years - VISION and IVY Networks, September 2024-January 2025.

MMWR: Morbidity and Mortality Weekly Report. 2025

2 Total citations

2 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

18 Years - VISION and IVY Networks, September 2023-January 2024.

MMWR: Morbidity and Mortality Weekly Report. 2024

51 Total citations

51 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.

Lancet (London, England). 2024

17 Total citations

17 Recent citations

n/a Field Citation Ratio

n/a Relative Citation Ratio

Accuracy of COVID-19-like illness diagnoses in electronic health record data: retrospective cohort study.

JMIR formative research. 2023

4 Total citations

4 Recent citations

3.65 Field Citation Ratio

2.01 Relative Citation Ratio

Effectiveness of BNT162b2 COVID-19 vaccination in children and adolescents.

Pediatrics. 2023

10 Total citations

10 Recent citations

9.08 Field Citation Ratio

0.79 Relative Citation Ratio

Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: an observational study of real-world data across 10 US states from August-December 2021.

Vaccine. 2023

7 Total citations

7 Recent citations

6.37 Field Citation Ratio

0.76 Relative Citation Ratio

Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions - VISION Network, September 2022-April 2023.

American Journal of Transplantation. 2023

8 Total citations

8 Recent citations

5.13 Field Citation Ratio

0.27 Relative Citation Ratio

Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods.

JAMA network open. 2023

66 Total citations

65 Recent citations

60 Field Citation Ratio

6.8 Relative Citation Ratio

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design.

Vaccine. 2023

5 Total citations

5 Recent citations

2.85 Field Citation Ratio

0.52 Relative Citation Ratio

Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance.

Journal of Infectious Diseases. 2023

6 Total citations

6 Recent citations

5.45 Field Citation Ratio

0.4 Relative Citation Ratio

Protection of two and three mRNA vaccine doses against severe outcomes among adults hospitalized with COVID-19--VISION Network, August 2021 to March 2022.

Journal of Infectious Diseases. 2023

12 Total citations

12 Recent citations

6.52 Field Citation Ratio

1.29 Relative Citation Ratio

Relationships between social vulnerability and coronavirus disease 2019 vaccination coverage and vaccine effectiveness.

Clinical Infectious Diseases. 2023

12 Total citations

12 Recent citations

10 Field Citation Ratio

1.88 Relative Citation Ratio

Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults - VISION Network, nine states, September-November 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

93 Total citations

91 Recent citations

50 Field Citation Ratio

3.92 Relative Citation Ratio

Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated - VISION Network, 10 states, December 2021-June 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

115

115 Total citations

75 Recent citations

62 Field Citation Ratio

6.16 Relative Citation Ratio

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

179

179 Total citations

100 Recent citations

97 Field Citation Ratio

10 Relative Citation Ratio

Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalizations among immunocompromised adults during SARS-CoV-2 Omicron predominance - VISION Network, 10 states, December 2021-August 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

71 Total citations

68 Recent citations

38 Field Citation Ratio

3.69 Relative Citation Ratio

Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during oeriods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

412

412 Total citations

160 Recent citations

113 Field Citation Ratio

25 Relative Citation Ratio

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-nine states, January-September 2021.

American Journal of Transplantation. 2022

12 Total citations

7 Recent citations

6.52 Field Citation Ratio

0.52 Relative Citation Ratio

Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022.

MMWR: Morbidity and Mortality Weekly Report. 2022

429

429 Total citations

204 Recent citations

232 Field Citation Ratio

26 Relative Citation Ratio

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study.

BMJ (Clinical research ed.). 2022

158

158 Total citations

155 Recent citations

83 Field Citation Ratio

10 Relative Citation Ratio

Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

176

176 Total citations

80 Recent citations

67 Field Citation Ratio

7.5 Relative Citation Ratio

Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity - nine states, January-September 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

100

100 Total citations

34 Recent citations

38 Field Citation Ratio

3.03 Relative Citation Ratio

Contact

full name

S. E. Reese

Quick Info

Publications

Collaboration

Co-author network

Map of science

S. E. Reese All authors

About

Publications While At HealthPartners

selected publications

Journal Article

Contact

full name

Quick Info

Publications Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Publications